Interleukin-5 pathway inhibition in the treatment of eosinophilic respiratory disorders
2016 · Current Opinion in Allergy and Clinical Immunology · 172 citations
https://doi.org/10.1097/aci.0000000000000251
D
Diego Bagnasco
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
177
Papers
3.5K
Citations
32
h-index
82
i10-index
Diego Bagnasco is an academic researcher from Ospedale Policlinico San Martino. The author has contributed to research in topics: Asthma and respiratory diseases & Respiratory and Cough-Related Research & Allergic Rhinitis and Sensitization. The author has an h-index of 32, co-authored 151 publications.
ORCID: 0000-0002-3661-5731Papers by this author
worksType 2 immunity in asthma
2018 · World Allergy Organization Journal · 154 citations
https://doi.org/10.1186/s40413-018-0192-5
Waterpipe smoking: not necessarily less hazardous than cigarette smoking
2013 · Netherlands Heart Journal · 73 citations
https://doi.org/10.1007/s12471-013-0501-0
Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life
2022 · Clinical and Molecular Allergy · 50 citations
https://doi.org/10.1186/s12948-022-00171-2
The North-Western Italian experience with anti IL-5 therapy amd comparison with regulatory trials
2018 · World Allergy Organization Journal · 44 citations
https://doi.org/10.1186/s40413-018-0210-7
Severe asthma: One disease and multiple definitions
2021 · World Allergy Organization Journal · 32 citations
https://doi.org/10.1016/j.waojou.2021.100606
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat